Cours Stemline Therapeutics, Inc.
Actions
US85858C1071
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 08/08/03 |
David Gionco
DFI | Director of Finance/CFO | 63 | 16/01/14 |
Jeffrey Levitt
CMP | Compliance Officer | - | 01/03/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 08/08/03 |
Varia. 1 janv. | Capi. | |
---|---|---|
-1,17% | 102 Md | |
+2,87% | 96,09 Md | |
+2,13% | 22,28 Md | |
-14,77% | 21,4 Md | |
-8,79% | 18,14 Md | |
-39,98% | 17,02 Md | |
-13,21% | 16,09 Md | |
+8,55% | 13,83 Md | |
+35,75% | 11,97 Md |